Another study demonstrated that CMTM6 knockdown reduced the expression of PD-L1 and increased the infiltration of CD8+ and CD4+ T cells, which enhanced antitumor immunity in head and neck squamous cell carcinoma (Chen et al., 2020b). The gene discussed is CMTM6; the disease is head and neck squamous cell carcinoma.